story of the week
Irbesartan in Marfan Syndrome (AIMS)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Irbesartan in Marfan Syndrome (AIMS): A Double-Blind, Placebo-Controlled Randomised Trial
Lancet 2019 Dec 10;[EPub Ahead of Print], M Mullen, XY Jin, A Child, AG Stuart, M Dodd, JA Aragon-Martin, D Gaze, A Kiotsekoglou, L Yuan, J Hu, C Foley, L Van Dyck, R Knight, T Clayton, L Swan, JDR Thomson, G Erdem, D Crossman, M FlatherFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.